Navigation Links
FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users
Date:10/1/2009

ne hematin method. In the study, Mirena (n=79) was compared to an approved first-line hormonal therapy, medroxyprogesterone acetate (n=81), over six menstrual cycles. Successful treatment was defined when two outcomes were met: 1) a proportion of subjects with end-of-study MBL < 80 mL and 2) a greater than or equal to 50% decrease in MBL from baseline to end-of-study. Mirena demonstrated a significantly superior reduction in MBL. Additionally, a greater number of women in the Mirena arm achieved successful treatment vs. those in the medroxyprogesterone acetate arm (85% vs. 22%: respectively, p=<0.001). The study excluded women with organic or systemic conditions that may cause heavy uterine bleeding (except fibroids, with total volume not > 5 mL). The most common reported adverse events for Mirena in the study were uterine bleeding/spotting at irregular intervals, headache, ovarian cysts, vaginitis, pain during menstruation (dysmenorrhea), pelvic pain, and breast tenderness.

About Mirena

Mirena (levonorgestrel-releasing intrauterine system) is a removable intrauterine contraceptive that delivers small amounts of hormone directly to the uterus. It is among the most efficacious forms of birth control and works for up to five years. Mirena received FDA approval for the prevention of pregnancy in December 2000. It is currently used by approximately two million women in the U.S. and has been used by more than 15 million women worldwide.(3)

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals operation of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the United States, Bayer HealthCare Pharmaceuticals comp
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
2. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
3. FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
4. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
5. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
6. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
7. FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
8. FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
9. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
10. FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
11. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Children,s National Health ... Sept. 29 at 5 p.m. EDT for its ... in response to continued strong interest from inventors.  ... will be awarded to the winning presentations at ... Symposium hosted by Children,s National in October. For ...
(Date:9/22/2014)... and SHANGHAI , Sept. ... (BHG), a global knowledge leader in healthcare technology, ... to support healthcare innovation in China ... connected health technologies. Continua and BHG announced this ... being held this week in Washington, ...
(Date:9/22/2014)... , Sept. 22, 2014 ... of the "Global Ablation Technologies (Radiofrequency, Ultrasound, ... 2019" report to their offering. ... the global ablation technologies market has been divided ... ultrasound, microwave, cryotherapy, hydrothermal, and hydromechanical ablation technologies. ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
(Date:9/23/2014)... 2014 Ale Gicqueau, President and Chairman ... Data Visualization for Clinical Trials at the upcoming ... Francisco on Friday, September 26, 2014. , PhUSE ... its inception, PhUSE has expanded from its roots as ... platform for the discussion of topics encompassing the work ...
(Date:9/23/2014)... 23, 2014 With the emergence of ... of all tobacco products, retail chains are transforming the ... to patients, customers, and shoppers. In this capacity, Inside ... retail pharmacy healthcare to share their knowledge on patient ... know to coordinate care with other colleagues inside the ...
(Date:9/23/2014)... Published by Nationwide Lifts, the book is designed to inspire ... mobility in a new way, using equipment that is affordable, ... that equipment and can bring mobility and freedom back ... business, I’ve seen so many people struggle with what to ... mobility issues,” said Andy Darnley, co-founder and president of Nationwide ...
(Date:9/23/2014)... Dallas-based luxury linen purveyor Peacock Alley ... as vice president of product development. Eades will be responsible ... primary lead on global sourcing for the company. In her ... product development group and sourcing group and will be the ... notes, "Peacock Alley is a brand I have admired for ...
(Date:9/23/2014)... Positioning themselves as the leading provider ... Tactical products to their basket which customers can ... good name in the market and customers believe in ... products and now customers will get a myriad of ... MilSpec Tactical Safe which uses an authentic military specification ...
Breaking Medicine News(10 mins):Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2Health News:Retail Pharmacies at the Forefront of Primary Care Innovation 2Health News:Nationwide Lifts, America’s Leader in Home Elevators, Is Proud to Announce the Release of Its First Book, “Stair Lifts: Move Up, Not Out!” 2Health News:Luxury Linen Purveyor Peacock Alley Announces New Vice President of Product Development 2Health News:GunSafes.com Now Offers Secure Tactical Range of Gun Safes 2
... of pesto sold in Ontario and Quebec following the warning ... not to eat two kinds of pesto – not to ... Sundried Tomatoes pesto - sold in Ontario and Quebec. ... affected products were sold in 200 ml glass jars in ...
... According to New York health officials, condoms would have more ... process of considering various options of casing the condoms. ... colourful subway theme. A novel way of wrapping the condom ... the same by the people. , ,On an ...
... created the world's first canine clone, have cloned another breed ... the water and bird hunting// skills. ,A ... College of Veterinary Medicine of Seoul National University (SNU) cloned ... team, formerly led by the nation's disgraced stem cell scientist ...
... an intranasal influenza vaccine using a novel adjuvant ... the first tablet// flu vaccine formulation. ... recently completed a preclinical study on intranasal formulation, ... start this autumn, and the vaccine will follow ...
... hope for treating those with nicotine addiction, scientists have come out ... brain called the insula can result in a person not wanting ... of the brain and is thought to translate information from other ... cravings for a drug. , The study published in ...
... points to folic acid being able to prevent facial clefts; ... British study//. , Pregnant women have been prescribed folic ... been understood to reduce the risk of babies being born ... a study conducted by Allen Wilcox of the National Institute ...
Cached Medicine News:Health News:Seoul Lab Clones Poodle 2Health News:Oral Flu Vaccine On The Horizon In Russia 2Health News:Chain-Smokers can Kick the Habit –A ‘brainy’ I 2
... ventricular drainage set (EVD set) ... for external ventricular drainage. It ... with a ventricular catheter or ... probe from the Aesculap Spiegelberg ...
... The Trippi-Wells and Universal tongs were ... are needed than can be safely provided ... ring. Titanium construction. Kit complete with four ... or four pin application. Skull pins at ...
... neuro and skull base surgery. Complete ... surgery, pediatric neurosurgery, bony defects of ... base regions, neuro trauma. Dedicated neuro/skull ... in one compact kit. MRI and ...
Hand Drill, with two-position Handle, with Jacob three-jaw chuck, wrench-locked for changing twist drills up to 6 mm...
Medicine Products: